Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    22649106 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Intervention: Drug: Ara-C, Mitoxantrone, Daunorubicin, Thioguanin
2 Completed Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
Condition: Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Drug: Thioguanine;   Drug: Daunorubicin;   Drug: Cyclophosphamide;   Drug: G-CSF;   Procedure: Autologous stem cell transplantation;   Procedure: Allogeneic stem cell transplantation

Study has passed its completion date and status has not been verified in more than two years.